Identifying TB co-infection : new approaches?

Similar documents
Approaches to LTBI Diagnosis

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

ESCMID Online Lecture Library. by author

In our paper, we suggest that tuberculosis and sarcoidosis are two ends of the same spectrum. Given the pathophysiological and clinical link between

TB Intensive Tyler, Texas December 2-4, 2008

Peggy Leslie-Smith, RN

Technical Bulletin No. 172

TB Intensive San Antonio, Texas November 11 14, 2014

Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year

Use of Interferon-γ Release Assays (IGRAs) in TB control in low and middle-income settings - EXPERT GROUP MEETING -

TB Intensive Houston, Texas October 15-17, 2013

QuantiFERON-TB Gold Plus

Diagnostic challenges of active childhood TB in Tanzania. Michala Vaaben Rose, MD, Ph.D Department of Infectious Diseases, Hvidovre

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB

Screening of HIV-Infected Patients with IGRAs for LTBI. Background. Tuberculosis is the most prevalent in the world.

TB Prevention Who and How to Screen

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010

Tuberculosis Tools: A Clinical Update

TUBERCULOSIS. Pathogenesis and Transmission

Barbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and Infectious Disease UT Health Northeast

of clinical laboratory diagnosis in Extra-pulmonary Tuberculosis

Effect of prolonged incubation time on the results of the QuantiFERON TB Gold In-Tube assay for the diagnosis of latent tuberculosis infection

APPLICATION OF IMMUNO CHROMATOGRAPHIC METHODS IN PLEURAL TUBERCULOSIS

Biomarkers for Tuberculosis. Robert S. Wallis, MD, FIDSA Senior Director, Pfizer

Making the Diagnosis of Tuberculosis

Diagnosis Latent Tuberculosis. Disclosures. Case

Interpretation of TST & IGRA results. Objectives

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University

Self-Study Modules on Tuberculosis

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

Diagnosis & Management of Latent TB Infection

Research Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012

Variation in T-SPOT.TB spot interpretation between independent observers of different laboratories

Didactic Series. Latent TB Infection in HIV Infection

Tuberculin Skin Test (TST) and Interferon-gamma Release Assays (IGRA)

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

Using Interferon Gamma Release Assays for Diagnosis of TB Infection

Title: Role of Interferon-gamma Release Assays in the Diagnosis of Pulmonary Tuberculosis in Patients with Advanced HIV infection

Detecting latent tuberculosis using interferon gamma release assays (IGRA)

T-CELL RESPONSES ASSESSED USING IGRA AND TST ARE NOT CORRELATED WITH AFB GRADE AND CHEST RADIOGRAPH IN PULMONARY TUBERCULOSIS PATIENTS

The Challenges and Pitfalls in Diagnosing or Misdiagnosing Tuberculosis: Are the Days of TB Skin Tests Over?

CHAPTER 3: DEFINITION OF TERMS

Report on WHO Policy Statements

Diagnosis and Medical Case Management of Latent TB. Bryan Rock, MD April 27, 2010

Conflict of Interest Disclosures:

Screening for Tuberculosis Infection. Harlingen, TX. Linda Dooley, MD has the following disclosures to make:

Thorax Online First, published on December 8, 2009 as /thx

International Journal of Innovative Research in Medical Science (IJIRMS)

Testing for TB. Bart Van Berckelaer Territory Manager Benelux. Subtitle

Preventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers. Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program

Utility of PPD or IGRA to answer the age old question of "TB or not TB

Laboratory Updates on IGRA Testing

CULTURE OR PCR WHAT IS

Role of subclinical TB: Can we model prevention of TB in the subclinical stages?

ORIGINAL ARTICLE. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients

How to interpret the new QuantiFERON- TB Gold Plus test (QFT-Plus)

New Standards for an Old Disease:

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Didactic Series. Latent TB Infection in HIV Infection

A Mobile Health Intervention Utilizing Community Partnership to Improve Access to Latent Tuberculosis Infection Treatment

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease

Evaluation of Mycobacterium tuberculosis specific T cell response to ESAT-6 and PPD antigen with ELISPOT assay

TB Update: March 2012

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

TB in Corrections Phoenix, Arizona

Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017

LIAISON QuantiFERON -TB Gold Plus Solution

Advanced Management of Patients with Tuberculosis Little Rock, Arkansas August 13 14, 2014

CHILDHOOD TUBERCULOSIS: NEW WRINKLES IN AN OLD DISEASE [FOR THE NON-TB EXPERT]

APSR RESPIRATORY UPDATES

INTENSIFIED TB CASE FINDING

Diagnosis and Medical Management of LTBI

A pilot study measuring the kinetic profile of IP-10 over the first 14 days of PTB chemotherapy

TB Intensive San Antonio, Texas December 1-3, 2010

Transmission and Pathogenesis of Tuberculosis

Latent TB Infection (LTBI)

LATENT TUBERCULOSIS. Robert F. Tyree, MD

Tuberculosis What you need to know. James Zoretic M.D., M.P.H. Regions 2 and 3 Director

TB Laboratory for Nurses

Supplementary webappendix

Tuberculosis Intensive

Tuberculosis Pathogenesis

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose

TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of

These recommendations will remain in effect until the national shortage of PPD solution has abated.

Investigation of false-positive results by the QuantiFERON-TB Gold In-Tube assay

Northwestern Polytechnic University

Latent tuberculosis infection

Nguyen Van Hung (NTP, Viet Nam)

ATTACHMENT 2. New Jersey Department of Health Tuberculosis Program FREQUENTLY ASKED QUESTIONS

Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines

Madhukar Pai, MD, PhD Jessica Minion, MD

Literature Overview. Health Economics. Experience with QuantiFERON -TB Gold. Cellestis Clinical Guide series

Tuberculin Skin Test (TST) and Interferon-gamma Release Assays (IGRA)

Factors Associated with Indeterminate and False Negative Results of QuantiFERON-TB Gold In-Tube Test in Active Tuberculosis

The Diagnosis of Active TB. Deborah McMahan, MD TB Intensive September 28, 2017

Transcription:

Identifying TB co-infection : new approaches? Charoen Chuchottaworn MD. Senior Medical Advisor, Central Chest Institute of Thailand, Department of Medical Services, MoPH

Primary tuberculosis Natural history Chemotherapy 90% 10% 98% 1-3% Nature Rev Immune 2011 doi:10.1038/nri2960

Nature Rev 2016;2:1-23

Diagnosis of Latent Tuberculosis Infection Current standard tests - Tuberculin skin test (TST) - Interferon-γ release assays (IGRA) - QuantiFERON Gold-in-Tube (QTF-GIT) - T.SPOT-TB New tests - QuantiFERON TB-Gold Plus - Gene expression pattern - Cytokines response pattern - T cell activation markers

Diagnosis of Tuberculosis Clinical signs and symptoms X-ray findings Demonstration of mycobacteria: smear and culture Demonstration of mycobacterial DNA/RNA Demonstration of mycobacterial antigens or antibodies Demonstration of host responses Histopathology

Moving from smear and staining to molecular test WHOrecommended rapid diagnostic - Smear and staining is not sensitive ( sensitivity 30-60% ) - Smear positive need 30,000 bacilli/ml. - Molecular test is more sensitive ( sensitivity 80-90% ) - WHO-recommended rapid diagnostic - WRD = Xpert MTB/RIF, Loopamp MTBC detection kit.

Evaluation of 5 novel proteins biomarkers for the diagnosis of pulmonary and extra-pulmonary tuberculosis : preliminary result

Evaluation of 5 novel proteins biomarkers for the diagnosis of pulmonary and extra-pulmonary tuberculosis : preliminary result

Evaluation of 5 novel proteins biomarkers for the diagnosis of pulmonary and extra-pulmonary tuberculosis : preliminary result

PNAS 2017;114:3969-74

Diagnosis of Latent Tuberculosis Infection Current standard tests - Tuberculin skin test (TST) - Interferon-γ release assays (IGRA) - QuantiFERON Gold-in-Tube (QTF-GIT) - T.SPOT-TB New tests - QuantiFERON TB-Gold Plus - Gene expression pattern - Cytokines response pattern - T cell activation markers

Comparing interferon gamma assays and tuberculin skin test for identifying latent tuberculosis infection that progress to active tuberculosis systematic review and meta-analysis BMC Infect Dis 2017;17-200-7

New Generation of IGRA Reasons of including CD8+ T cells stimulations are - CD8+ T cells can produce Inferferon-γ without CD4+ T cells - Response of CD8+ T cells correlates well with bacterial loads - Response of CD8+ T cells was decreased after 24 weeks of Rx Antigens used in both tests (QTF-GIT and QFTplus) QTF-GIT QTF plus one tube tube 1 (TB1) tube 2(TB2) ESAT6, CFP10, 7.7 Long chain of Short chain of ESAT6, CFP10 ESAT6, CFP10 nil tube nil tube mitogen tube mitogen tube

Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan

Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan

Eur Respir J 2016;48:1411-9.

Eur Respir J 2016;48:1411-9.

Eur Respir J 2016;48:1411-9.

ESAT-6 CFP-10 Am J Respir Crit Care Med 2015;192:485-99.

PPD TB : infected vs uninfected = IFN-γ, IP-10,TNF-α, IL2 LTBI vs Disease = TNF-α, IL-1ra, IL-10 Am J Respir Crit Care Med 2015;192:485-99.

- Measure CD27 T- lymphocyte in Blood - Active TB had low CD27 T- lymphocyte in blood Lancet Inf Dis 2014;14:931-38

Gene Expression Assay Venepuncture of whole blood Convert to cdna Cell lysis and stabilize RNA with Extract RNA Prepare PCR reaction mixture and us cdna as template Generate nano-droplets ( approximately 20000 droplets) in PCR mixture (1 droplet = 1 nano-litre = 1 primer-pairs) PCR Quantitatify nano-droplets Demonstrate as Ratio to control house-keeping gene

Gene expression Quantitative PCR - Create nano-droplets - PCR in nano-droplets - Count positive and negative nanodroplets

J Mol Med 2007;85:613-21

J Mol Med 2007;85:613-21

Set of 393 genes Nature 2010;466:973-9.

Nature 2010;466:973-9.

N Eng J Med 2014;370:1712-23

N Eng J Med 2014;370:1712-23

N Eng J Med 2014;370:1712-23

Gene Immun 2015;16:253-60

Gene Immun 2015;16:253-60

Tuberculosis 2016;100:25-31.

Tuberculosis 2016;100:25-31.

BMC Med 2017;15:67-83

Summary - IGRA is useful test to determine tuberculosis infection but not correlate with activity of disease and alternative test of cytokines releasing assay profile seems to be more correlate with disease activity. - Serologic tests do not have high enough sensitivity to use in clinical practice unless new specific antigens could be defined. - Gene expression profile is a promising test to differentiate TB disease, latent tuberculosis infection progressing to disease and healthy patient. - Urine LAM antigen test is a useful routine test for identifying tuberculosis infection in HIV infected patients.